{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:19:29Z","timestamp":1783937969497,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Bacterial vaginosis (BV) is associated with non-optimal changes in the vaginal microbiome and increased susceptibility to STIs and HIV in cisgender women. Much less is known about the sexual health of transmasculine people and susceptibility to BV, STIs, and HIV. This study's objective was to assess BV testing and outcomes of transmasculine and cisgender women patient populations at a large, LGBTQ\u2009+\u2009federally qualified health center.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective electronic health record data were extracted for eligible patients having at least one primary care visit between January 1, 2021, and December 31, 2021. Transmasculine patients were limited to those with a testosterone prescription in 2021. We conducted log binomial regression analysis to determine the probability of receiving a BV test based on gender identity, adjusting for sociodemographic characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During 2021, 4,903 cisgender women patients and 1,867 transmasculine patients had at least one primary care visit. Compared to cisgender women, transmasculine patients were disproportionately young, White, queer, privately insured, living outside Chicago, and had a lower rate of BV testing (1.9% v. 17.3%, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). Controlling for sociodemographics, transmasculine patients were less likely to receive a BV test [Prevalence Ratio\u2009=\u20090.19 (95% CI 0.13\u20130.27)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The low rate of BV testing among transmasculine patients may contribute to disparities in reproductive health outcomes. Prospective community- and provider-engaged research is needed to better understand the multifactorial determinants for sexual healthcare and gender-affirming care for transmasculine patients. In particular, the impact of exogenous testosterone on the vaginal microbiome should also be determined.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frph.2024.1344111","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:01:02Z","timestamp":1708405262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Bacterial vaginosis testing gaps for transmasculine patients may exacerbate health disparities"],"prefix":"10.3389","volume":"6","author":[{"given":"Hale M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Rusie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya D.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0083722","DOI":"10.1128\/jcm.00837-22","article-title":"State of the art for diagnosis of bacterial vaginosis","volume":"61","author":"Muzny","year":"2023","journal-title":"J Clin Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.maturitas.2016.05.015","article-title":"Menopause and the vaginal microbiome","volume":"91","author":"Muhleisen","year":"2016","journal-title":"Maturitas"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00593-20","article-title":"Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise","volume":"5","author":"Song","year":"2020","journal-title":"mSphere"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/aje\/kwab147","article-title":"Perceived stress and molecular bacterial vaginosis in the national institutes of health longitudinal study of vaginal flora","volume":"190","author":"Turpin","year":"2021","journal-title":"Am J Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmi.2018.04.019","article-title":"The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis","volume":"25","author":"Tamarelle","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fcimb.2020.00354","article-title":"Bacterial vaginosis: current diagnostic avenues and future opportunities","volume":"10","author":"Redelinghuys","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e74378","DOI":"10.1371\/journal.pone.0074378","article-title":"The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis","volume":"8","author":"Bilardi","year":"2013","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/COC.0000000000000893","article-title":"Breast and cervical cancer screening disparities in transgender people","volume":"45","author":"Oladeru","year":"2022","journal-title":"Am J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"20779","DOI":"10.7448\/IAS.19.3.20779","article-title":"Inequities in access to HIV prevention services for transgender men: results of a global survey of men who have sex with men","volume":"19","author":"Scheim","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.15585\/mmwr.mm6633a3","article-title":"HIV testing among transgender women and men\u201427 states and Guam, 2014\u20132015","volume":"66","author":"Pitasi","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/sextrans-2020-054474","article-title":"Sociodemographic and behavioural factors associated with testing for HIV and STIs in a US nationwide sample of transgender men who have sex with men","volume":"96","author":"Antebi-Gruszka","year":"2020","journal-title":"Sex Transm Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1093\/cid\/ciac370","article-title":"Trans-inclusive sexual health questionnaire to improve human immunodeficiency virus\/sexually transmitted infection (STI) care for transgender patients: anatomic site-specific STI prevalence and screening","volume":"76","author":"Tordoff","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"769950","DOI":"10.3389\/fcimb.2021.769950","article-title":"The effect of gender-affirming medical care on the vaginal and neovaginal microbiomes of transgender and gender-diverse people","volume":"11","author":"Krakowsky","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1373\/clinchem.2018.293654","article-title":"The vaginal microbiome of transgender men","volume":"65","author":"Winston McPherson","year":"2019","journal-title":"Clin Chem"},{"key":"B16","first-page":"371","article-title":"Vaginal microbiome","volume":"83","author":"Buchta","year":"2018","journal-title":"Ceska Gynekol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.353.6297.331","article-title":"Infectious disease. Vaginal microbiome affects HIV risk","volume":"353","author":"Cohen","year":"2016","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4158\/EP-2017-0203","article-title":"Estrogen levels do not rise with testosterone treatment for transgender men","volume":"24","author":"Chan","year":"2018","journal-title":"Endocr Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s10815-019-01558-y","article-title":"Ovarian stimulation for fertility preservation or family building in a cohort of transgender men","volume":"36","author":"Adeleye","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/dc.25030","article-title":"Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone","volume":"50","author":"Lin","year":"2022","journal-title":"Diagn Cytopathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1072700","DOI":"10.3389\/frph.2023.1072700","article-title":"Temporary changes in STI & HIV testing & diagnoses across different phases of the COVID-19 pandemic, Chicago IL","volume":"5","author":"Pyra","year":"2023","journal-title":"Front Reprod Health"},{"key":"B22","volume-title":"Guidelines for the Primary and Gender-affirming Care of Transgender and Gender Nonbinary People","author":"Deutsch","year":"2016"},{"key":"B23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/lgbt.2020.0232","article-title":"The pre-exposure prophylaxis cascade in at-risk transgender men who have sex with men in the United States","volume":"8","author":"Reisner","year":"2021","journal-title":"LGBT Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10461-022-03826-y","article-title":"PrEP use and adherence among transgender persons in Chicago, IL (SHIPP study, 2014\u20132018, USA)","author":"Townes","year":"2023","journal-title":"AIDS Behav"},{"key":"B25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/09540121.2016.1271937","article-title":"Barriers and facilitators to HIV and sexually transmitted infections testing for gay, bisexual, and other transgender men who have sex with men","volume":"29","author":"Scheim","year":"2017","journal-title":"AIDS Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1179334","DOI":"10.3389\/frph.2023.1179334","article-title":"Young, Black\/African American, and Latino communities are left behind despite legislative efforts in California to reduce HIV\/STI disparities","volume":"5","author":"Gaines","year":"2023","journal-title":"Front Reprod Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1152\/ajpendo.00111.2015","article-title":"Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men","volume":"308","author":"Borst","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.12998\/wjcc.v3.i4.338","article-title":"Review of health risks of low testosterone and testosterone administration","volume":"3","author":"Jia","year":"2015","journal-title":"World J Clin Cases"},{"key":"B29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1128\/jcm.18.1.170-177.1983","article-title":"Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid","volume":"18","author":"Spiegel","year":"1983","journal-title":"J Clin Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1914729","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ijc.33967","article-title":"Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening","volume":"151","author":"Arbyn","year":"2022","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1128\/JCM.01710-09","article-title":"Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis","volume":"48","author":"Forney","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/lgbt.2016.0143","article-title":"Understanding transgender men\u2019s experiences with and preferences for cervical cancer screening: a rapid assessment survey","volume":"4","author":"Seay","year":"2017","journal-title":"LGBT Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/lgbt.2016.0187","article-title":"Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests","volume":"4","author":"McDowell","year":"2017","journal-title":"LGBT Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/OLQ.0000000000001533","article-title":"Erasure and health equity implications of using binary male\/female categories in sexual health research and human immunodeficiency virus\/sexually transmitted infection surveillance: recommendations for transgender-inclusive data collection and reporting","volume":"49","author":"Tordoff","year":"2022","journal-title":"Sex Transm Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10461-010-9859-9","article-title":"Transmen in San Francisco: what do we know from HIV test site data?","volume":"15","author":"Chen","year":"2011","journal-title":"AIDS Behav"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e25981","DOI":"10.1002\/jia2.25981","article-title":"HIV Prevalence among transmasculine individuals at a New York city community health centre: a cross-sectional study","volume":"25","author":"Radix","year":"2022","journal-title":"J Int AIDS Soc"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1344111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:01:06Z","timestamp":1708405266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1344111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":39,"alternative-id":["10.3389\/frph.2024.1344111"],"URL":"https:\/\/doi.org\/10.3389\/frph.2024.1344111","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"article-number":"1344111"}}